PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 10464293-4 1999 The endogenous VIP gene and a 5.2-kilobase pair (kb) VIP-luciferase reporter gene, are up-regulated by phorbol 12-myristate 13-acetate (PMA) in SK-N-SH neuroblastoma cells. Tetradecanoylphorbol Acetate 103-134 vasoactive intestinal peptide Homo sapiens 15-18 10464293-4 1999 The endogenous VIP gene and a 5.2-kilobase pair (kb) VIP-luciferase reporter gene, are up-regulated by phorbol 12-myristate 13-acetate (PMA) in SK-N-SH neuroblastoma cells. Tetradecanoylphorbol Acetate 136-139 vasoactive intestinal peptide Homo sapiens 53-56 10464293-4 1999 The endogenous VIP gene and a 5.2-kilobase pair (kb) VIP-luciferase reporter gene, are up-regulated by phorbol 12-myristate 13-acetate (PMA) in SK-N-SH neuroblastoma cells. Tetradecanoylphorbol Acetate 103-134 vasoactive intestinal peptide Homo sapiens 53-56 10464293-4 1999 The endogenous VIP gene and a 5.2-kilobase pair (kb) VIP-luciferase reporter gene, are up-regulated by phorbol 12-myristate 13-acetate (PMA) in SK-N-SH neuroblastoma cells. Tetradecanoylphorbol Acetate 136-139 vasoactive intestinal peptide Homo sapiens 15-18 8197564-8 1994 Incubation experiments revealed a simultaneous in vitro release of VIP and PP with a significant increase by either carbachol or phorbol myristate acetate but not by theophylline or caerulein. Tetradecanoylphorbol Acetate 129-154 vasoactive intestinal peptide Homo sapiens 67-70 8863492-7 1996 In contrast to reports that the VIP-CRE imparts 12-O-tetradecanoylphorbol 13-acetate (phorbol 12-myristate 13-acetate; PMA) responsiveness to heterologous promoters, PMA stimulation in SK-N-SH cells was independent of an intact VIP-CRE but dependent on a region between -2.5 kb and the VIP-CRE. Tetradecanoylphorbol Acetate 48-84 vasoactive intestinal peptide Homo sapiens 32-35 8863492-7 1996 In contrast to reports that the VIP-CRE imparts 12-O-tetradecanoylphorbol 13-acetate (phorbol 12-myristate 13-acetate; PMA) responsiveness to heterologous promoters, PMA stimulation in SK-N-SH cells was independent of an intact VIP-CRE but dependent on a region between -2.5 kb and the VIP-CRE. Tetradecanoylphorbol Acetate 86-117 vasoactive intestinal peptide Homo sapiens 32-35 7716283-1 1994 Vasoactive intestinal peptide (VIP) primed the respiratory burst of human neutrophils induced by phorbol myristate acetate (PMA) and by the chemotactic peptide N-formyl-Met-Leu-Phe (fMLP). Tetradecanoylphorbol Acetate 97-122 vasoactive intestinal peptide Homo sapiens 31-34 7716283-1 1994 Vasoactive intestinal peptide (VIP) primed the respiratory burst of human neutrophils induced by phorbol myristate acetate (PMA) and by the chemotactic peptide N-formyl-Met-Leu-Phe (fMLP). Tetradecanoylphorbol Acetate 124-127 vasoactive intestinal peptide Homo sapiens 31-34 8197564-10 1994 Octreotide (somatostatin analogue [SMS 201-995]) significantly inhibited the carbachol and phorbol myristate acetate-stimulated VIP and PP release. Tetradecanoylphorbol Acetate 91-116 vasoactive intestinal peptide Homo sapiens 128-131 1372239-4 1992 IL-1 alpha amplified the effect of phorbol myristate acetate to increase the VIP content of chromaffin cells, but antagonized phorbol ester-induced elevation of neurotensin levels. Tetradecanoylphorbol Acetate 35-60 vasoactive intestinal peptide Homo sapiens 77-80 8194586-1 1994 Vasoactive intestinal peptide (VIP) primed the respiratory burst of human neutrophils in response to phorbol myristate acetate. Tetradecanoylphorbol Acetate 101-126 vasoactive intestinal peptide Homo sapiens 31-34 1319016-3 1992 A short-term treatment of cells with PMA did however result in a 5-fold transient increase in VIP mRNA; prior differentiation with retinoic acid or dBcAMP diminished this effect. Tetradecanoylphorbol Acetate 37-40 vasoactive intestinal peptide Homo sapiens 94-97 27932441-13 2017 MAIN RESULTS AND THE ROLE OF CHANCE: Trophoblast CM and 10 nM VIP promoted neutrophil deactivation by preventing phorbol myristate acetate-induced NET formation and ROS synthesis while they increased neutrophil spontaneous apoptosis and reversed the anti-apoptotic effect of lipopolysaccharide (all P < 0.05 versus control). Tetradecanoylphorbol Acetate 113-138 vasoactive intestinal peptide Homo sapiens 62-65 1279891-3 1992 Treatment with Bt2cAMP and TPA markedly increased the number of cells immunoreactive to VIP, PHM, neuropeptide Y, Met-enkephalin, substance P and tyrosine hydroxylase and also the contents of VIP and Met-enkephalin in the culture medium. Tetradecanoylphorbol Acetate 27-30 vasoactive intestinal peptide Homo sapiens 88-91 1279891-3 1992 Treatment with Bt2cAMP and TPA markedly increased the number of cells immunoreactive to VIP, PHM, neuropeptide Y, Met-enkephalin, substance P and tyrosine hydroxylase and also the contents of VIP and Met-enkephalin in the culture medium. Tetradecanoylphorbol Acetate 27-30 vasoactive intestinal peptide Homo sapiens 192-195 2416313-1 1985 The effects of dibutyryl cAMP (Bt2cAMP) and phorbol esters such as 12-O-tetradecanoylphorbol-13-acetate (TPA) and phorbol-12,13-didecanoate (PDD) on VIP/PHM-27 gene expression in human neuroblastoma cells in culture were investigated. Tetradecanoylphorbol Acetate 67-103 vasoactive intestinal peptide Homo sapiens 149-152 2416313-1 1985 The effects of dibutyryl cAMP (Bt2cAMP) and phorbol esters such as 12-O-tetradecanoylphorbol-13-acetate (TPA) and phorbol-12,13-didecanoate (PDD) on VIP/PHM-27 gene expression in human neuroblastoma cells in culture were investigated. Tetradecanoylphorbol Acetate 67-103 vasoactive intestinal peptide Homo sapiens 153-159 1727435-6 1992 Vasoactive intestinal peptide (VIP) reproduced the forskolin-like stimulation but stimulated also other, TPA, and/or Ca2(+)-like protein phosphorylations. Tetradecanoylphorbol Acetate 105-108 vasoactive intestinal peptide Homo sapiens 0-29 1727435-6 1992 Vasoactive intestinal peptide (VIP) reproduced the forskolin-like stimulation but stimulated also other, TPA, and/or Ca2(+)-like protein phosphorylations. Tetradecanoylphorbol Acetate 105-108 vasoactive intestinal peptide Homo sapiens 31-34 3200839-4 1988 Treatment with 10 nM phorbol 12-myristate 13-acetate (PMA) stimulated VIP peptide levels approximately 5-fold in SH-SY-5Y cells but did not increase appreciably VIP levels in the other subclones. Tetradecanoylphorbol Acetate 21-52 vasoactive intestinal peptide Homo sapiens 70-73 3200839-4 1988 Treatment with 10 nM phorbol 12-myristate 13-acetate (PMA) stimulated VIP peptide levels approximately 5-fold in SH-SY-5Y cells but did not increase appreciably VIP levels in the other subclones. Tetradecanoylphorbol Acetate 54-57 vasoactive intestinal peptide Homo sapiens 70-73 2839091-1 1988 We have previously shown that the VIP precursor contains a novel PHI-27-like peptide, PHM-27, and that the synthesis of the prepro-VIP/PHM-27 mRNA is induced with cAMP and TPA in human neuroblastoma cells. Tetradecanoylphorbol Acetate 172-175 vasoactive intestinal peptide Homo sapiens 34-37 2839091-1 1988 We have previously shown that the VIP precursor contains a novel PHI-27-like peptide, PHM-27, and that the synthesis of the prepro-VIP/PHM-27 mRNA is induced with cAMP and TPA in human neuroblastoma cells. Tetradecanoylphorbol Acetate 172-175 vasoactive intestinal peptide Homo sapiens 124-134 2839091-1 1988 We have previously shown that the VIP precursor contains a novel PHI-27-like peptide, PHM-27, and that the synthesis of the prepro-VIP/PHM-27 mRNA is induced with cAMP and TPA in human neuroblastoma cells. Tetradecanoylphorbol Acetate 172-175 vasoactive intestinal peptide Homo sapiens 135-141